Sort
40,608 grants matching “prostate cancer”
Development of VN/14-1 and Related Analogs for Breast Cancer Therapy
$547,355Vincent Collins Ofuka Njar · Thomas Jefferson University · R01 · FY2010 · CA
ENCAPSULATION OF CHEMOTHERAPY DRUGS IN NOVEL POLYPEPTIDE VESICLES FOR TARGETING AND DELIVERY TO PROSTATE CANCER CELLS
$547,283University Of California, Los Angeles · · FY2009 · Department of the Army
Race, Comorbidity & Long Term Prostate Cancer Outcomes
$547,201David F Penson · University Of Southern California · R01 · FY2008 · CA
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens
$547,060Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2022 · EB
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer
$546,985William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$546,963Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2024 · CA
SIMULTANEOUS LIGAND-DIRECTED CYTOTOXIC TOXIN AND ENDOSOME DISRUPTOR DELIVERY TO ABLATE PROSTATE CANCER
$546,913University Of Arizona · · FY2017 · Department of the Army
Centrosome instability as a mechanism to promote localized prostate cancer
$546,835Gregory Charles Rogers · University Of Arizona · R01 · FY2022 · CA
GENOME WIDE ANALYSIS OF GERMLINE CNPS AND SNPS IN PROSTATE CANCER
$546,814Wake Forest University Health Sciences · · FY2008 · Department of Defense
ROLE OF ETV1 IN PROSTATE CANCER
$546,807University Of Oklahoma · · FY2008 · Department of Defense
Development of large-field-of-view hyperpolarized MRI
$546,632Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
ENVIRONMENT &GLI GENES IN NORMAL DEVELOPMENT &DISEASE
$546,555Children'S Memorial Hospital (Chicago) · P01 · FY2002 · ES
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository
$546,507Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Atlanta Regional Community Clinical Oncology Program
$546,482St. Joseph'S Hospital · U10 · FY2004 · CA
AMPLIFICATION OF TYPE II CADHERINS IN PROSTATE CANCER
$546,409The University Of Texas Health Science Center At San Antonio · · FY2008 · Department of Defense
Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis
$546,334Lauren Keith · Imbio, Llc · R44 · FY2015 · CA
Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force
$546,174Kathryn R Nightingale · Duke University · R01 · FY2017 · CA
Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung
$546,151Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Nuclear and non-nuclear functions of NKX3.1 in suppression of prostate cancer
$546,133Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2025 · CA
Incorporating residential histories into assessment of cancer risk in a predominantly low-income and racially diverse population
$546,132Melinda Aldrich · Vanderbilt University Medical Center · R01 · FY2024 · CA
Systemic RNA Delivery to Tumors
$546,127Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2023 · CA
Systemic RNA Delivery to Tumors
$546,127Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2025 · CA
Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer
$546,037Jiang He · University Of Virginia · R01 · FY2022 · CA
Modeling Perineural Invasion Using a Bioorthogonally Integrated Hydrogel Platform
$545,960Xinqiao Jia · University Of Delaware · · FY2018 · MPS
Pathogenesis of human prostate carcinomas
$545,950Pradip Roy-Burman · University Of Southern California · R01 · FY2006 · CA